Serveur d'exploration sur Pittsburgh

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

Identifieur interne : 000421 ( Main/Exploration ); précédent : 000420; suivant : 000422

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

Auteurs : Linwah Yip [États-Unis]

Source :

RBID : pubmed:25155423

Descripteurs français

English descriptors

Abstract

Molecular markers including gene expression profiles, somatic gene alterations, and circulating peripheral markers have augmented diagnostic, prognostic, and therapeutic options for thyroid cancer patients.

DOI: 10.1002/jso.23768
PubMed: 25155423


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.</title>
<author>
<name sortKey="Yip, Linwah" sort="Yip, Linwah" uniqKey="Yip L" first="Linwah" last="Yip">Linwah Yip</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Endocrine Surgery and Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Division of Endocrine Surgery and Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25155423</idno>
<idno type="pmid">25155423</idno>
<idno type="doi">10.1002/jso.23768</idno>
<idno type="wicri:Area/PubMed/Corpus">000903</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000903</idno>
<idno type="wicri:Area/PubMed/Curation">000903</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000903</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000903</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000903</idno>
<idno type="wicri:Area/Ncbi/Merge">003153</idno>
<idno type="wicri:Area/Ncbi/Curation">003153</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003153</idno>
<idno type="wicri:Area/Main/Merge">000421</idno>
<idno type="wicri:Area/Main/Curation">000421</idno>
<idno type="wicri:Area/Main/Exploration">000421</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.</title>
<author>
<name sortKey="Yip, Linwah" sort="Yip, Linwah" uniqKey="Yip L" first="Linwah" last="Yip">Linwah Yip</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Endocrine Surgery and Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Division of Endocrine Surgery and Surgical Oncology, Department of Surgery, University of Pittsburgh, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of surgical oncology</title>
<idno type="eISSN">1096-9098</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antineoplastic Agents (therapeutic use)</term>
<term>Biomarkers, Tumor (genetics)</term>
<term>Gene Expression Regulation, Neoplastic (drug effects)</term>
<term>Humans</term>
<term>Molecular Targeted Therapy</term>
<term>Prognosis</term>
<term>Thyroid Neoplasms (diagnosis)</term>
<term>Thyroid Neoplasms (genetics)</term>
<term>Thyroid Neoplasms (therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Antinéoplasiques (usage thérapeutique)</term>
<term>Humains</term>
<term>Marqueurs biologiques tumoraux (génétique)</term>
<term>Pronostic</term>
<term>Régulation de l'expression des gènes tumoraux ()</term>
<term>Thérapie moléculaire ciblée</term>
<term>Tumeurs de la thyroïde ()</term>
<term>Tumeurs de la thyroïde (diagnostic)</term>
<term>Tumeurs de la thyroïde (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Biomarkers, Tumor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antineoplastic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Thyroid Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Tumeurs de la thyroïde</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Gene Expression Regulation, Neoplastic</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Thyroid Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Marqueurs biologiques tumoraux</term>
<term>Tumeurs de la thyroïde</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Thyroid Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antinéoplasiques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Molecular Targeted Therapy</term>
<term>Prognosis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Pronostic</term>
<term>Régulation de l'expression des gènes tumoraux</term>
<term>Thérapie moléculaire ciblée</term>
<term>Tumeurs de la thyroïde</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Molecular markers including gene expression profiles, somatic gene alterations, and circulating peripheral markers have augmented diagnostic, prognostic, and therapeutic options for thyroid cancer patients.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Pennsylvanie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Yip, Linwah" sort="Yip, Linwah" uniqKey="Yip L" first="Linwah" last="Yip">Linwah Yip</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000421 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000421 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25155423
   |texte=   Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25155423" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PittsburghV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021